Early Lymphocyte Recovery Is an Important Determinant of Outcome Following Allogeneic Transplantation With CD34+ Selected Graft and Limited T-Cell Addback

Bone Marrow Transplantation - United Kingdom
doi 10.1038/sj.bmt.1704082
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Predictors of Recovery Following Allogeneic CD34+-selected Cell Infusion Without Conditioning to Correct Poor Graft Function

Haematologica
Hematology
2019English

Donor T-Lymphocyte Infusion for Unrelated Allogeneic Bone Marrow Transplantation With CD3+ T-Cell-Depleted Graft

Bone Marrow Transplantation
TransplantationHematology
2003English

Individually Adjusted Prophylactic Donor Lymphocyte Infusions After CD34-selected Allogeneic Peripheral Blood Stem Cell Transplantation

Bone Marrow Transplantation
TransplantationHematology
2001English

Early Fluid Overload Is a Serious Toxicity Associated With an Increased Risk of Non-Relapse Mortality After Ex-Vivo CD34-Selected Allogeneic Hematopoietic Cell Transplantation

Biology of Blood and Marrow Transplantation
TransplantationHematology
2018English

CD34+-Selected Stem Cell Boost Without Further Conditioning for Poor Graft Function After Allogeneic Stem Cell Transplantation in Patients With Hematological Malignancies

Biology of Blood and Marrow Transplantation
TransplantationHematology
2014English

CD34-selected Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Relapsed, High-Risk Multiple Myeloma

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2015English

Effect of Total Nucleated and CD34+ Cell Dose on Outcome After Allogeneic Hematopoietic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation
TransplantationHematology
2015English

Early T-Cell Chimerism Is Valuable in Predicting Early Mortality From Steroid-Resistant Acute Graft Versus Host Disease After Myeloablative Allogeneic Haematopoietic Cell Transplantation

Biology of Blood and Marrow Transplantation
TransplantationHematology
2014English

CD34+ Selected Ex-Vivo T-Cell Depleted (TCD) Grafts for Allogeneic Hematopoietic Cell Transplantation (Allo-Hsct) Is Associated With Low Incidence of Acute and Chronic Graft-Versus-Host Disease (GVHD) and High Chronic-GVHD/Relapse-Free Survival

Biology of Blood and Marrow Transplantation
TransplantationHematology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy